Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

552
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
552
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

2.1K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.1K
Drug Discovery: Overview01:26

Drug Discovery: Overview

13.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.3K
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

1.8K
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
1.8K
Preclinical Development: Overview01:28

Preclinical Development: Overview

6.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.4K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

2.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identifying Inferior ST-Segment Elevation Myocardial Infarction in the Presence of Left Bundle Branch Block: Seeing Through the Block.

JACC. Case reports·2026
Same author

Correction: Chemoprevention of Colon Carcinogenesis by Oleanolic Acid and Its Analog in Male F344 Rats and Modulation of COX-2 and Apoptosis in Human Colon HT-29 Cancer Cells.

Pharmaceutical research·2026
Same author

Hologenomic analysis of rectal mucus sampling for detection of adenomatous polyps and colorectal cancer.

Nature communications·2025
Same author

LHFPL5 is required for maximal activation of the mechanotransduction channel in cochlear hair cells.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Trends in use of the new MeSH term "overdiagnosis": A bibliometric review.

Health information and libraries journal·2025
Same author

Dapagliflozin-Associated Hepatotoxicity With a Positive Rechallenge.

ACG case reports journal·2025

Related Experiment Video

Updated: Apr 1, 2026

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

3.4K

Predictive Value Tools as an Aid in Chemopreventive Agent Development.

Barbara K Dunn1, Vernon E Steele2, Richard M Fagerstrom2

  • 1Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland (BKD, VES, RMF, RL, LGF, BSK); CCS Associates, Inc., McLean, VA (CFT); Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC (DR); Information Management Services, Rockville, MD (CC). dunnb@mail.nih.gov.

Journal of the National Cancer Institute
|October 1, 2015
PubMed
Summary

Early-stage morphologic assays can predict cancer drug efficacy in animal models. The aberrant crypt focus (ACF) assay is particularly effective for colon cancer, and combining assays improves prediction.

More Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

9.3K
In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

14.8K

Related Experiment Videos

Last Updated: Apr 1, 2026

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
16:02

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

3.4K
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

9.3K
In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

14.8K

Area of Science:

  • Oncology
  • Chemoprevention Research
  • Translational Science

Background:

  • The National Cancer Institute's chemopreventive agent testing program has evaluated approximately 800 agents over 25 years.
  • Key stages include in vitro/in vivo morphologic assays and animal tumor assays.
  • The study aimed to assess the predictive accuracy of early-stage morphologic assays for later-stage animal tumor assay outcomes.

Purpose of the Study:

  • To determine the predictive accuracy of established morphologic assays for chemopreventive agent efficacy.
  • To evaluate how well six common morphologic assays predict outcomes in animal tumor assays.
  • To identify specific morphologic assays that are strong predictors for different cancer types.

Main Methods:

  • Statistical modeling was applied to data from 210 agents tested in both morphologic and animal tumor assays.
  • Multimodel inference was used to generate three models predicting tumor outcomes (all types, mammary, colon).
  • Each morphologic assay was assigned a predictive value for each set of animal tumor assays.

Main Results:

  • Significant differences were observed in the predictive value of morphologic assays.
  • The aberrant crypt focus (ACF) assay showed strong predictive ability for colon cancer efficacy in animal models.
  • Combining less predictive assays can enhance overall predictive power.

Conclusions:

  • Morphologic assays demonstrate varying predictive capabilities for chemopreventive agent efficacy.
  • The ACF assay is a valuable predictor for colon cancer chemoprevention.
  • Developing predictive models can optimize the selection of agents and assays, improving chemopreventive development efficiency.